Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  L-leucovorin
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-5 of 5 for your search:
Start Over
Panitumumab and RAS, DIagnostically-useful Gene Mutation for mCRC
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 20 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: Panitumumab-3001, U1111-1164-9167, NCT02394795
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000691166, WCTU-COPERNICUS, EUDRACT-2010-023083-40, EU-21087, CRUK-C23134/A11537, CARDIFF-SPON830-10, WCTU-COPERNICUS, EU-21087, NCT01263171
Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: ATOM, UMIN000010209, NCT01836653
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: KSCC1301, NCT02280070
Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: ATOM Exploratory study, UMIN000010429, NCT01834014
Start Over